CXCR3 Chemokine Receptor-Ligand Interactions in the Lymph Node Optimize CD4+ T Helper 1 Cell Differentiation

Immunity

Volumn 37, Issue 6, 2012, Pages 1091-1103

  Groom, Joanna R ^a,c   Richmond, Jillian ^a   Murooka, Thomas T ^a   Sorensen, Elizabeth W ^a   Sung, Jung Hwan ^b   Bankert, Katherine ^a   von Andrian, Ulrich H ^b   Moon, James J ^a   Mempel, Thorsten R ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HEMATOPOIETIC CELL; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; TH1 CELL; UPREGULATION; VACCINATION;

ANIMALS; CELL DIFFERENTIATION; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHEMOKINES, CXC; CYTOKINES; DENDRITIC CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; LIGANDS; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; MICE; MICE, TRANSGENIC; PROTEIN BINDING; RECEPTORS, CXCR3; TH1 CELLS;

EID: 84870864876     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.08.016     Document Type: Article

References (41)

1. Bromley S.K., Mempel T.R., Luster A.D. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 2008, 9:970-980.
2. Celli S., Garcia Z., Bousso P. CD4 T cells integrate signals delivered during successive DC encounters in vivo. J. Exp. Med. 2005, 202:1271-1278.
3. Cervantes-Barragan L., Lewis K.L., Firner S., Thiel V., Hugues S., Reith W., Ludewig B., Reizis B. Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc. Natl. Acad. Sci. USA 2012, 109:3012-3017.
4. Dufour J.H., Dziejman M., Liu M.T., Leung J.H., Lane T.E., Luster A.D. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 2002, 168:3195-3204.
5. Friedman R.S., Jacobelli J., Krummel M.F. Surface-bound chemokines capture and prime T cells for synapse formation. Nat. Immunol. 2006, 7:1101-1108.
6. Gattass C.R., King L.B., Luster A.D., Ashwell J.D. Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes. J. Exp. Med. 1994, 179:1373-1378.
7. Groom J.R., Luster A.D. CXCR3 in T cell function. Exp. Cell Res. 2011, 317:620-631.
8. Groom J.R., Luster A.D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 2011, 89:207-215.
9. Hancock W.W., Lu B., Gao W., Csizmadia V., Faia K., King J.A., Smiley S.T., Ling M., Gerard N.P., Gerard C. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 2000, 192:1515-1520.
10. Hickman H.D., Takeda K., Skon C.N., Murray F.R., Hensley S.E., Loomis J., Barber G.N., Bennink J.R., Yewdell J.W. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat. Immunol. 2008, 9:155-165.
11. Hu J.K., Kagari T., Clingan J.M., Matloubian M. Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation. Proc. Natl. Acad. Sci. USA 2011, 108:E118-E127.
12. Hugues S. Dynamics of dendritic cell-T cell interactions: a role in T cell outcome. Semin. Immunopathol. 2010, 32:227-238.
13. Iannacone M., Moseman E.A., Tonti E., Bosurgi L., Junt T., Henrickson S.E., Whelan S.P., Guidotti L.G., von Andrian U.H. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 2010, 465:1079-1083.
14. Ingulli E., Mondino A., Khoruts A., Jenkins M.K. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J. Exp. Med. 1997, 185:2133-2141.
15. Itano A.A., McSorley S.J., Reinhardt R.L., Ehst B.D., Ingulli E., Rudensky A.Y., Jenkins M.K. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003, 19:47-57.
16. Kohlmeier J.E., Reiley W.W., Perona-Wright G., Freeman M.L., Yager E.J., Connor L.M., Brincks E.L., Cookenham T., Roberts A.D., Burkum C.E., et al. Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infection. J. Exp. Med. 2011, 208:1621-1634.
17. Kurachi M., Kurachi J., Suenaga F., Tsukui T., Abe J., Ueha S., Tomura M., Sugihara K., Takamura S., Kakimi K., Matsushima K. Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration. J. Exp. Med. 2011, 208:1605-1620.
18. Marshall H.D., Chandele A., Jung Y.W., Meng H., Poholek A.C., Parish I.A., Rutishauser R., Cui W., Kleinstein S.H., Craft J., Kaech S.M. Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection. Immunity 2011, 35:633-646.
19. Martín-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 2004, 5:1260-1265.
20. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., Allende M.L., Proia R.L., Cyster J.G. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
21. Mempel T.R., Henrickson S.E., Von Andrian U.H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004, 427:154-159.
22. Miller M.J., Safrina O., Parker I., Cahalan M.D. Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J. Exp. Med. 2004, 200:847-856.
23. Molon B., Gri G., Bettella M., Gómez-Moutón C., Lanzavecchia A., Martínez-A C., Mañes S., Viola A. T cell costimulation by chemokine receptors. Nat. Immunol. 2005, 6:465-471.
24. Moon J.J., Chu H.H., Pepper M., McSorley S.J., Jameson S.C., Kedl R.M., Jenkins M.K. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007, 27:203-213.
25. Moon J.J., Dash P., Oguin T.H., McClaren J.L., Chu H.H., Thomas P.G., Jenkins M.K. Quantitative impact of thymic selection on Foxp3+ and Foxp3- subsets of self-peptide/MHC class II-specific CD4+ T cells. Proc. Natl. Acad. Sci. USA 2011, 108:14602-14607.
26. Nakanishi Y., Lu B., Gerard C., Iwasaki A. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009, 462:510-513.
27. Obst R., van Santen H.M., Mathis D., Benoist C. Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. J. Exp. Med. 2005, 201:1555-1565.
28. Oxenius A., Bachmann M.F., Ashton-Rickardt P.G., Tonegawa S., Zinkernagel R.M., Hengartner H. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 1995, 25:3402-3411.
29. Padovan E., Spagnoli G.C., Ferrantini M., Heberer M. IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J. Leukoc. Biol. 2002, 71:669-676.
30. Park M.K., Amichay D., Love P., Wick E., Liao F., Grinberg A., Rabin R.L., Zhang H.H., Gebeyehu S., Wright T.M., et al. The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J. Immunol. 2002, 169:1433-1443.
31. Pepper M., Pagán A.J., Igyártó B.Z., Taylor J.J., Jenkins M.K. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 2011, 35:583-595.
32. Quezada S.A., Jarvinen L.Z., Lind E.F., Noelle R.J. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 2004, 22:307-328.
33. Rabin R.L., Park M.K., Liao F., Swofford R., Stephany D., Farber J.M. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J. Immunol. 1999, 162:3840-3850.
34. Rabin R.L., Alston M.A., Sircus J.C., Knollmann-Ritschel B., Moratz C., Ngo D., Farber J.M. CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions. J. Immunol. 2003, 171:2812-2824.
35. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 1998, 187:875-883.
36. Sierro F., Biben C., Martínez-Muñoz L., Mellado M., Ransohoff R.M., Li M., Woehl B., Leung H., Groom J., Batten M., et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 2007, 104:14759-14764.
37. Tang H.L., Cyster J.G. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999, 284:819-822.
38. Varga S.M., Welsh R.M. High frequency of virus-specific interleukin-2-producing CD4(+) T cells and Th1 dominance during lymphocytic choriomeningitis virus infection. J. Virol. 2000, 74:4429-4432.
39. Yoneyama H., Narumi S., Zhang Y., Murai M., Baggiolini M., Lanzavecchia A., Ichida T., Asakura H., Matsushima K. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J. Exp. Med. 2002, 195:1257-1266.
40. Yoneyama H., Matsuno K., Zhang Y., Nishiwaki T., Kitabatake M., Ueha S., Narumi S., Morikawa S., Ezaki T., Lu B., et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 2004, 16:915-928.
41. *). Annu. Rev. Immunol. 2010, 28:445-489.